Economic evaluation of interventions in endocrinology

Endocrinol Metab Clin North Am. 1997 Mar;26(1):67-87. doi: 10.1016/s0889-8529(05)70234-6.

Abstract

This article provides a review of methods for conducting cost-effectiveness, cost-utility, and cost-benefit studies. Economic evaluations of interventions designed to improve outcomes of patients with diabetes and osteoporosis are reviewed, and key issues for future research are discussed. The role of cost-effectiveness analysis in reimbursement decision making at the public and private levels is explored.

Publication types

  • Review

MeSH terms

  • Cost-Benefit Analysis
  • Costs and Cost Analysis
  • Diabetes Mellitus / economics
  • Diabetes Mellitus / therapy
  • Diabetic Nephropathies / economics
  • Diabetic Nephropathies / therapy
  • Diabetic Retinopathy / economics
  • Diabetic Retinopathy / therapy
  • Endocrine System Diseases / economics
  • Endocrine System Diseases / therapy
  • Endocrinology / economics*
  • Humans
  • Osteoporosis / economics
  • Osteoporosis / therapy